Plasma p-tau217: from ‘new kid’ to most promising candidate for Alzheimer’s disease blood test

por Teunissen, Charlotte E, Thijssen, Elisabeth H, Verberk, Inge M W
Publicado 2020

Deciphering Protein Secretion from the Brain to Cerebrospinal Fluid for Biomarker Discovery

por Waury, Katharina, de Wit, Renske, Verberk, Inge M. W., Teunissen, Charlotte E., Abeln, Sanne
Publicado 2023

High efavirenz levels but not neurofilament light plasma levels are associated with poor neurocognitive functioning in asymptomatic HIV patients

por Hakkers, Charlotte S., Hermans, Anne Marie, van Maarseveen, Erik M., Teunissen, Charlotte E., Verberk, Inge M. W., Arends, Joop E., Hoepelman, Andy I. M.
Publicado 2020

Highly specific and ultrasensitive plasma test detects Abeta(1–42) and Abeta(1–40) in Alzheimer’s disease

por Thijssen, Elisabeth H., Verberk, Inge M. W., Vanbrabant, Jeroen, Koelewijn, Anne, Heijst, Hans, Scheltens, Philip, van der Flier, Wiesje, Vanderstichele, Hugo, Stoops, Erik, Teunissen, Charlotte E.
Publicado 2021

Serum Neurofilament light correlates with CADASIL disease severity and survival

por Gravesteijn, Gido, Rutten, Julie W., Verberk, Inge M. W., Böhringer, Stefan, Liem, Michael K., van der Grond, Jeroen, Aartsma‐Rus, Annemieke, Teunissen, Charlotte E., Lesnik Oberstein, Saskia A. J.
Publicado 2018

CSF or serum neurofilament light added to α‐Synuclein panel discriminates Parkinson's from controls

por Oosterveld, Linda P., Verberk, Inge M.W., Majbour, Nour K., El‐Agnaf, Omar M., Weinstein, Henry C., Berendse, Henk W., Teunissen, Charlotte E., van de Berg, Wilma D.J.
Publicado 2019

Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline

por Stockmann, Julia, Verberk, Inge M. W., Timmesfeld, Nina, Denz, Robin, Budde, Brian, Lange-Leifhelm, Julia, Scheltens, Philip, van der Flier, Wiesje M., Nabers, Andreas, Teunissen, Charlotte E., Gerwert, Klaus
Publicado 2020

Correction to: Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline

por Stockmann, Julia, Verberk, Inge M. W., Timmesfeld, Nina, Denz, Robin, Budde, Brian, Lange-Leifhelm, Julia, Scheltens, Philip, van der Flier, Wiesje M., Nabers, Andreas, Teunissen, Charlotte E., Gerwert, Klaus
Publicado 2021

Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological Changes

por Verberk, Inge M. W., Slot, Rosalinde E., Verfaillie, Sander C. J., Heijst, Hans, Prins, Niels D., van Berckel, Bart N. M., Scheltens, Philip, Teunissen, Charlotte E., van der Flier, Wiesje M.
Publicado 2018

Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease

por Janelidze, Shorena, Teunissen, Charlotte E., Zetterberg, Henrik, Allué, José Antonio, Sarasa, Leticia, Eichenlaub, Udo, Bittner, Tobias, Ovod, Vitaliy, Verberk, Inge M. W., Toba, Kenji, Nakamura, Akinori, Bateman, Randall J., Blennow, Kaj, Hansson, Oskar
Publicado 2021

Differential diagnostic performance of a panel of plasma biomarkers for different types of dementia

por Thijssen, Elisabeth H., Verberk, Inge M.W., Kindermans, Jana, Abramian, Adlin, Vanbrabant, Jeroen, Ball, Andrew J., Pijnenburg, Yolande, Lemstra, Afina W., van der Flier, Wiesje M., Stoops, Erik, Hirtz, Christophe, Teunissen, Charlotte E.
Publicado 2022

Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231

por Bayoumy, Sherif, Verberk, Inge M. W., den Dulk, Ben, Hussainali, Zulaiga, Zwan, Marissa, van der Flier, Wiesje M., Ashton, Nicholas J., Zetterberg, Henrik, Blennow, Kaj, Vanbrabant, Jeroen, Stoops, Erik, Vanmechelen, Eugeen, Dage, Jeffrey L., Teunissen, Charlotte E.
Publicado 2021

Association of plasma biomarkers with cognitive function in persons with dementia and cognitively healthy in the Democratic Republic of Congo

por Ikanga, Jean, Patel, Saranya Sundaram, Roberts, Blaine R., Schwinne, Megan, Hickle, Sabrina, Verberk, Inge M. W., Epenge, Emmanuel, Gikelekele, Guy, Tshengele, Nathan, Kavugho, Immaculee, Mampunza, Samuel, Yarasheski, Kevin E., Teunissen, Charlotte E., Stringer, Anthony, Levey, Allan, Alonso, Alvaro
Publicado 2023

Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis

por De Meyer, Steffi, Schaeverbeke, Jolien M., Verberk, Inge M. W., Gille, Benjamin, De Schaepdryver, Maxim, Luckett, Emma S., Gabel, Silvy, Bruffaerts, Rose, Mauroo, Kimberley, Thijssen, Elisabeth H., Stoops, Erik, Vanderstichele, Hugo M., Teunissen, Charlotte E., Vandenberghe, Rik, Poesen, Koen
Publicado 2020

Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease

por Chatterjee, Pratishtha, Pedrini, Steve, Stoops, Erik, Goozee, Kathryn, Villemagne, Victor L., Asih, Prita R., Verberk, Inge M. W., Dave, Preeti, Taddei, Kevin, Sohrabi, Hamid R., Zetterberg, Henrik, Blennow, Kaj, Teunissen, Charlotte E., Vanderstichele, Hugo M., Martins, Ralph N.
Publicado 2021

CSF Biomarkers Reflecting Protein Pathology and Axonal Degeneration Are Associated with Memory, Attentional, and Executive Functioning in Early-Stage Parkinson′s Disease

por Oosterveld, Linda P., Kuiper, Tessa I., Majbour, Nour K., Verberk, Inge M. W., van Dijk, Karin D., Twisk, Jos W. R., El-Agnaf, Omar M., Teunissen, Charlotte E., Weinstein, Henry C., Klein, Martin, Berendse, Henk W., van de Berg, Wilma D. J.
Publicado 2020

Risk of dementia in APOE ε4 carriers is mitigated by a polygenic risk score

por Ebenau, Jarith L., van der Lee, Sven J., Hulsman, Marc, Tesi, Niccolò, Jansen, Iris E., Verberk, Inge M.W., van Leeuwenstijn, Mardou, Teunissen, Charlotte E., Barkhof, Frederik, Prins, Niels D., Scheltens, Philip, Holstege, Henne, van Berckel, Bart N.M., van der Flier, Wiesje M.
Publicado 2021

Association of CSF, Plasma, and Imaging Markers of Neurodegeneration With Clinical Progression in People With Subjective Cognitive Decline

por Ebenau, Jarith L., Pelkmans, Wiesje, Verberk, Inge M.W., Verfaillie, Sander C.J., van den Bosch, Karlijn A., van Leeuwenstijn, Mardou, Collij, Lyduine E., Scheltens, Philip, Prins, Niels D., Barkhof, Frederik, van Berckel, Bart N.M., Teunissen, Charlotte E., van der Flier, Wiesje M.
Publicado 2022

Plasma biomarkers predict amyloid pathology in cognitively normal monozygotic twins after 10 years

por den Braber, Anouk, Verberk, Inge M W, Tomassen, Jori, den Dulk, Ben, Stoops, Erik, Dage, Jeffrey L, Collij, Lyduine E, Barkhof, Frederik, Willemsen, Gonneke, Nivard, Michel G, van Berckel, Bart N M, Scheltens, Philip, Visser, Pieter Jelle, de Geus, Eco J C, Teunissen, Charlotte E
Publicado 2023

A Head-to-Head Comparison Between Plasma pTau181 and Tau PET Along the Alzheimer’s Disease Continuum

por Coomans, Emma M., Verberk, Inge M.W., Ossenkoppele, Rik, Verfaillie, Sander C.J., Visser, Denise, Gouda, Mariam, Tuncel, Hayel, Wolters, Emma E., Timmers, Tessa, Windhorst, Albert D., Golla, Sandeep S.V., Scheltens, Philip, van, Wiesje M., der Flier, van Berckel, Bart N.M., Teunissen, Charlotte E.
Publicado 2023